Literature DB >> 2091621

Pharmacologic management of ventricular arrhythmias after the cardiac arrhythmia suppression trial.

J Morganroth1, J T Bigger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2091621     DOI： 10.1016/0002-9149(90)91362-a

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  4 in total

1.  Pharmacoeconomic considerations in antiarrhythmic therapy.

Authors:  P J Podrid; R J Arnold; D J Kaniecki
Journal:  Pharmacoeconomics       Date:  1992-12       Impact factor: 4.981

Review 2.  Ventricular arrhythmias in congestive heart failure: clinical significance and management.

Authors:  G R Khoshnevis; A Massumi
Journal:  Tex Heart Inst J       Date:  1999

Review 3.  Propafenone. A reappraisal of its pharmacology, pharmacokinetics and therapeutic use in cardiac arrhythmias.

Authors:  H M Bryson; K J Palmer; H D Langtry; A Fitton
Journal:  Drugs       Date:  1993-01       Impact factor: 9.546

4.  Arrhythmias in Patients with Heart Failure.

Authors:  B. John Hynes; Jerry C. Luck; Deborah L. Wolbrette; John Boehmer; Gerald V. Naccarelli
Journal:  Curr Treat Options Cardiovasc Med       Date:  2002-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.